Introduction
============

Schwann cells (SCs) are the predominant cell type constituting the structure of peripheral nerves, and are crucial in repair and regeneration following peripheral nerve injury (PNI) ([@b1-mmr-14-02-1187]). Following PNI, SCs can activate macrophages to remove necrotic debris in the early stage, and provide a channel for regeneration ([@b2-mmr-14-02-1187]). SCs not only form the Büngner band to guide axonal regeneration, they also secrete neurotrophic factors, extracellular matrix and cell adhesion molecules to promote nerve regeneration ([@b3-mmr-14-02-1187]). However, autologous SCs are difficult to obtain and expand to sufficient numbers in a short duration; this is due to limitations in tissue availability, morbidity of the donor site and the sacrifice one or more functioning nerves with consequential loss of sensation ([@b4-mmr-14-02-1187]). The ideal features of transplantable cells are that they are readily available, proliferate rapidly *in vitro* and have characteristics of low or no immunogenicity.

Mesenchymal stem cells (MSCs) are an attractive cell source for the regeneration of nerve tissue due to their self-renewal ability, high growth rate and multipotent differentiation properties ([@b5-mmr-14-02-1187]). Bone marrow-derived mesenchymal stem cells (BMMSCs) can differentiate into an SC phenotype ([@b6-mmr-14-02-1187]), as well as express myelin-associated markers and remyelinate when transplanted into injured sciatic nerves of rats ([@b7-mmr-14-02-1187]). However, the isolation of BMMSCs is an invasive and painful procedure, and the ratio of MSCs in the bone marrow is relatively low (\<1/100,000) ([@b8-mmr-14-02-1187]). Therefore, an alternative cell source is in urgent demand. Adipose-derived stem cells (ADSCs) have similar phenotypic and gene expression profiles to BMMSCs. ADSCs also have unique advantages: They can be readily harvested using a safe and conventional liposuction procedure from subcutaneous fat tissue; the ratio of ADSCs in adipose tissue is higher than in BMMSCs (\~1--2%); and ADSCs proliferate significantly faster than BMMSCs ([@b9-mmr-14-02-1187]). It has also been reported that ADSCs can be transdifferentiated to exhibit an SC phenotype ([@b10-mmr-14-02-1187]).

In the present study, the transdifferentiation of rat ADSCs into Schwann-like cells was performed, and immunofluorescence, western blot and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) experiments were performed to detect glial fibrillary acidic protein (GFAP), S100 and p75. The mitotic feature of Schwann-like cells was also assessed. The present study aimed to provide a foundation for future experiments regarding the suitable selection of seed cells for nerve tissue engineering in the treatment of PNI.

Materials and methods
=====================

Animals
-------

A total of four male Wistar rats (age, 3--4 weeks) were obtained from the Experimental Animal Centre of China Medical University (Shenyang, China; no. SYXK Liao 2013-0001). The rats were housed in plastic cages at 24°C, 50% humidity, under a 12-h light/dark cycle with access to food and water *ad libitum*. In the present study, the mice were anesthetized using 10% chloral hydrate (350g/kg) and sacrificed using chloral hydrate (700g/kg) following adipose tissue sampling. The study protocol was approved by the Animal Experimental Committee of the China Medical University.

ADSC isolation and culture
--------------------------

The ADSCs were carefully isolated from rat inguinal fat pads, dissected and minced under aseptic conditions. Subsequently, the tissue was enzymatically dissociated at 37°C for 60 min using 0.1% collagenase I (Invitrogen; Thermo Fisher Scientific, Inc.). The dissociated cells were cultured in Dulbecco\'s modified Eagle\'s medium/F12 (DMEM/F12; Genview, Tallahassee, FL, USA) containing 10% fetal bovine serum (FBS; Biological Industries, Kibbutz Beit Haemek, Israel) and 1% (v/v) penicillin/streptomycin solution for 48 h at 37°C in 5% CO~2~. The non-adherent cells were removed on replacement of the medium every 2--3 days when the cells reached 80% confluence.

ADSC multilineage differentiation potential
-------------------------------------------

Rat ADSCs at the fourth passage were seeded into 6-well plates at a density of 1×10^5^ cells/ml and divided into experimental and control groups. Once the cells reached 80% confluence, the experimental group was cultured in induction medium. To induce osteogenic differentiation, the ADSCs were cultured at 37°C in 5% CO~2~ for 28 days in DMEM/F12 supplemented with 10% FBS, 0.1 *µ*M dexamethasone, 10 *µ*M β-glycerol phosphate and 50 *µ*M ascorbate, and calcium deposition was visualized by staining with Alizarin Red (Sigma-Aldrich, St. Louis, MO, USA). To induce adipogenic differentiation, the ADSCs were cultured for 14 days in DMEM/F12 supplemented with 10% FBS, 1 *µ*M dexamethasone, 5 *µ*g/ml insulin, 0.5 mM isobutylmethylxanthine (IBMX) and 100 *µ*M indomethacin, and adipogenesis was evaluated by observing the production of intracellular lip droplets, detected using Oil-Red O (Sigma-Aldrich) and observed with a Nikon Eclipse 80i microscope (Nikon Corporation, Toyko, Japan).

Characterization of ADSC surface molecules using flow cytometry
---------------------------------------------------------------

Rat ADSCs at the fourth passage were harvested by trypsinization, following which the cells were fixed in neutralized 4% paraformaldehyde for 30 min at a density of 1×10^6^ cells/ml, and then incubated with the following antibodies: Hamster fluorescein isothiocyanate (FITC)-conjugated CD29 (1:100; cat. no. 11-0291), phycoerythrin (PE)-conjugated CD31 (1:100; cat. no. 25-0310), mouse FITC-conjugated CD45 (1:200; cat. no. 11-0461), mouse allophycocyanin-conjugated CD49 (1:50; cat. no. 17-1490) and mouse PE-conjugated CD44 (1:400; cat. no. 12-0444), from eBioscience, Inc. (San Diego, CA, USA), and mouse FITC-conjugated CD106 (1:100; BD Biosciences, Franklin Lakes, NJ, USA) at 4°C for 30 min. The numbers of immunoreactive cells were detected using BD FACSDiva 7.0 (BD Biosciences), whereas cells stained with PBS (0.01 M; pH 7.4) served as a control.

Induction of ADSCs into an SC phenotype
---------------------------------------

When the rat ADSCs in the fourth passage were subconfluent, the medium was replaced with fresh medium containing 1 mM β-mercaptoethanol (β-ME; Sigma-Aldrich) for 24 h. The cells were then cultured in DMEM/F12 supplemented with 10% FBS and 35 ng/ml alltrans-retinoic acid (Sigma-Aldrich) for 72 h at 37°C in 5% CO~2~. Subsequently, the cells (1×10^6^ cells/ml) were incubated in SC-conditioned medium containing 10% FBS, 14 *µ*M forskolin (FSK; Alexis Biochemichals, San Diego, CA, USA), 5 ng/ml platelet-derived growth factor-AA (PeproTech, Rocky Hill, NJ, USA), 10 ng/ml basic fibroblast growth factor (bFGF; PeproTech) and 200 ng/ml recombinant human heregulin-β1 (HRG; PeproTech) for 12 days at 37°C in 5% CO~2~. The cells were passaged with trypsin/EDTA when required, and fresh medium was added approximately every 72 h.

Identification of Schwann-like cells
------------------------------------

### Immunofluorescence

For immunocytochemical assessment of the differentiated ADSC markers, the ADSCs were cultured in SC-conditioned medium for 12--14 days, and were then fixed in 4% (W/V) paraformaldehyde for 30 min. The fixed cells were blocked with goat serum for 1 h at room temperature. The polyclonal primary antibodies, rabbit polyclonal GFAP (1:200; cat. no. sc-9065), S100 (1:200; cat. no. sc-28533) and p75 NGF receptor protein (P75, 1:200; cat. no. sc-5634), all from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA) were added and incubated at 4°C overnight. Following incubation, goat anti-rabbit Cy3- (1:100; cat. no. SA00003-2) or FITC-conjugated (1:100; cat. no. SA00009-2) secondary antibodies (Proteintech Group, Inc., Chicago, IL, USA) were added at 37°C for 1 h. The cell nuclei were labeled using DAPI (Sigma-Aldrich). PBS was substituted for primary antibodies as a control. The cells were visualized and recorded using a fluorescence microscope (Nikon Eclipse 80i).

### Western blot analysis

Rat ADSCs in the fourth passage were harvested by trypsinization, and 1×10^6^ cells/ml were fixed in 100 *µ*l protein isolation, followed by centrifugation at 12,000 g for 30 min at 4°C. The cell lysates were analyzed using a commercial bicinchoninic acid assay kit (cat. no. BCA01; Beijing Dingguo Biotech, Co., Ltd. Beijing, China). A total of 30 *µ*g protein was prepared per sample, and denatured at 95°C for 5 min. The proteins were resolved by 15 or 12% SDS-PAGE (Beijing Dingguo Biotech, Co., Ltd.) and transferred onto PVDF membranes. The membranes were blocked in 5% bovine serum albumin for 1 h, and then incubated overnight at 4°C with GFAP, S100, P75 and GAPDH primary antibodies (1:10,000, Proteintech Group, Inc.). The membranes were then incubated with goat anti-mouse (cat. no. L3032-1/2) and anti-rabbit (cat. no. L3012-1/2) IgG-horseradish peroxidase-conjugated secondary antibodies (1:10,000; Signalway Antibody, College Park, MD, USA) for 1 h at 37°C. The blots were scanned using a ChemiDoc XRS+ image analysis system (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and analyzed using Image J software (National Institutes of Health, Bethesda, MD, USA).

### mRNA extraction and RT-qPCR analysis

The total mRNA was isolated from rat ADSCs in the fourth passage using RNA Isolator Total RNA Extraction reagent (Vazyme, Piscataway, NJ, USA). The mRNA was detected using an Ace-Hi™ One Step Quantitative Real-Time PCR SYBR Green kit (cat. no. Q221-01; Vazyme) and RT-qPCR was performed using an LCS 480 real-time PCR system, according to the manufacturers\' protocols. The primers were provided as follows: S-100, forward 5-CTTGATTTGCTTCAGGGATGA-3 and reverse 5-CCCACAGAGTGTTGATTTCG-3; P75, forward 5-TTTGCTTGCTGTTGGAATGA-3 and reverse 5-ATGCTCCTG GTCTCTTCA CC-3; GFAP, forward 5-GCTCCAAGATGAAACCAACC-3 and reverse 5-CCAGCGACTCAACCTTCCT-3); GAPDH, forward 5-GGAGCGTGGCTACTCTTTTG-3 and reverse 5-GGCTGGAAGAGTGTCTCAGG-3. The reaction conditions were as follows: Stage one, reverse transcription involving one cycle of 50°C for 30 min; stage two, predegeneration involving one cycle of 95°C for 10 min; stage three, cyclic reaction involving 40 cycles of 95°C for 10 sec and 60°C for 30 sec; stage four, melting curve (one cycle, default). The relative expression value of each mRNA was calculated using the 2^−∆∆Cq^ method ([@b11-mmr-14-02-1187]), and normalized to that of GAPDH mRNA for each data point.

Proliferation assay of Schwann-like cells
-----------------------------------------

### 3-(4,5-dimethyl-2- thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay

To assess cell proliferation, an MTT (Sigma-Aldrich) assay was performed. Briefly, following culture for 1, 3, 5, 7, 9 and 11 days, the Schwann-like cells were seeded into 96-well plates at a density of 2×10^4^ cells/ml, and cultured for 24 h at 37°C in 5% CO~2~. Subsequently, MTT (5 mg/ml, 20 *µ*l/well) was added at 37°C for 4 h, following which the culture medium was carefully removed, and 150 *µ*l dimethyl sulfoxide was added to each well. The culture plate was then placed on a shaker and agitated at a low speed for 10 min. The absor bance density of each well was measured using an enzyme-linked immunometric meter (Multiskan Ascent, Thermo Fisher Scientific, Inc.) at 490 nm.

Observation and recording of the growth state of cells
------------------------------------------------------

The growth states of the Schwann-like cells were observed and recorded under an inverted microscope (BH2; Olympus Corporation, Tokyo, Japan) every day.

Statistical analysis
--------------------

The experiments for each group were run in triplicate. Data were expressed as the mean ± standard deviation. Statistical analysis was performed using SPSS 17.0 software (SPSS, Inc., Chicago, IL, USA). Student\'s paired-sample *t*-test was used for between-group comparisons of the means. One-way analysis of variance was used for the comparison of multiple groups. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

ADSC isolation and identification
---------------------------------

After 24 h primary culture, the rat ADSCs had adhered with a short spindle or polygonal shape ([Fig. 1A](#f1-mmr-14-02-1187){ref-type="fig"}), whereas at 72 h, the cell density was increased, and fibroblast-like colonies had formed. After 1 week, the ADSCs exhibited a uniformly aligned monolayer of fibroblast-like cells, with a swirl or parallel growth style ([Fig. 1B](#f1-mmr-14-02-1187){ref-type="fig"}). Between the first and fifth passages, the growth of the ADSCs was marked. However, the cells appeared irregular and larger in size at passage 10, and showed reduced proliferation ([Fig. 1C](#f1-mmr-14-02-1187){ref-type="fig"}).

The multipotent differentiation characteristic was demonstrated by culturing the cells with osteogenic medium and adipogenic medium. As shown in [Fig. 1D](#f1-mmr-14-02-1187){ref-type="fig"}, a calcific knob was visualized following staining with Alizarin Red, and small adipose drops had gathered intracellularly, detected using Oil-Red O, as shown in [Fig. 1E](#f1-mmr-14-02-1187){ref-type="fig"}. As shown in [Fig. 1F--H](#f1-mmr-14-02-1187){ref-type="fig"}, the primary cultured ADSCs expressed positively for CD29 (99.3%) and CD44 (94.3%), but not for CD 49 (1.3%), CD45 (0.1%), CD106 (0.0%) or CD 31 (0.0%), indicating that the cells were MSCs, but were not from hematopoietic stem cells.

Induction of ADSCs to differentiate into Schwann-like cells
-----------------------------------------------------------

The rat ADSCs were treated with SC-conditioned medium for 12 days. At the beginning of differentiation, the morphology of the ADSCs changed from a monolayer of large cells with a flat morphology to a small number of bipolar or tripolar spindle-like shaped cells ([Fig. 2A](#f2-mmr-14-02-1187){ref-type="fig"}). As the cells continued to proliferate, the density of cells was markedly increased ([Fig. 2B](#f2-mmr-14-02-1187){ref-type="fig"}). The results of the immunofluorescence ([Fig. 2C--E](#f2-mmr-14-02-1187){ref-type="fig"}), western blot ([Table I](#tI-mmr-14-02-1187){ref-type="table"}, [Fig. 2F--I](#f2-mmr-14-02-1187){ref-type="fig"}) and RT-qPCR ([Fig. 2J](#f2-mmr-14-02-1187){ref-type="fig"}) analyses showed that almost all the differentiated ADSCs were positive for GFAP, S100 and P75. These characteristics of differentiated ADSCs were similar to those of SCs.

Observation of the proliferation of Schwann-like cells
------------------------------------------------------

In the present study, the viability and proliferation of the Schwann-like cells were analyzed using an MTT assay. As shown in [Fig. 3A](#f3-mmr-14-02-1187){ref-type="fig"}, during the first 1--3 days, the cells grew slowly. The rate of cell proliferation increased more rapidly from day 3, and this rapid growth rate continued until day 7. Between days 9 and 11, the cells continue to grow, however, the growth rate had declined. During the experiment, images were captured of mitosis in the Schwann-like cells in each period. The chromatin filament formed a spiral shape, resembling a loose knitting ball, during prophase of mitosis ([Fig. 3B](#f3-mmr-14-02-1187){ref-type="fig"}). During metaphase ([Fig. 3C](#f3-mmr-14-02-1187){ref-type="fig"}), the chromosomes arranged in order at the equator and, during anaphase ([Fig. 3D](#f3-mmr-14-02-1187){ref-type="fig"}), the two chromatids of each chromosome separated and moved in the opposite directions. The chromatids divided into two groups and the cells were elongated, exhibiting a dumbbell-like shape. In telophase ([Fig. 3E](#f3-mmr-14-02-1187){ref-type="fig"}), gradual unwinding of the chromatids was observed, with one cell dividing into two cells.

Discussion
==========

Considerable attention has been focused on PNI due to its increased rate of morbidity. Once PNI occurs, the major physical response of the body is to protect the remaining neurons around the damage zone and restructure the axon ([@b12-mmr-14-02-1187]). In previous studies of SCs, the glial cells of the peripheral nervous system, they were shown to be involved in nerve regeneration by secreting neurotrophic factors ([@b13-mmr-14-02-1187]). However, Evans *et al* ([@b14-mmr-14-02-1187]) demonstrated that the effects of SCs were also concentration-dependent and distance-dependent, with more marked regenerative effects on nerve degeneration with increasing concentration in conduits, and a larger area of the distal axonal regeneration. Despite this, cultured SCs have limited clinical application, whereas stem cells are readily accessible as an alternative cell source for nerve regeneration.

It has been reported that MSCs can be readily derived from bone marrow for autologuous transplantation in *in vitro* ([@b15-mmr-14-02-1187]) and *in vivo* ([@b16-mmr-14-02-1187]) studies. Due to the complicated procurement and survival of SCs, this alternative cell source requires further investigation. ADSCs, which are isolated from adipose tissue, exhibit self-renewal and can differentiate along several mesenchymal tissue lineages, including adipocytes, osteoblasts, myocytes, chondrocytes and endothelial cells ([@b17-mmr-14-02-1187],[@b18-mmr-14-02-1187]). Liposuction is a common and safe surgical procedure, enabling a substantial number of cells to be obtained with minimal risk ([@b19-mmr-14-02-1187]). Furthermore the ratio of ADSCs in adipose tissue is higher than that of BMMSCs, and ADSCs proliferate significantly more rapidly, compared with BMMSCs,. Therefore, ADSCs may be an idea alternative cell source to SCs. It has also been reported that ADSCs can be induced into SCs *in vitro* ([@b10-mmr-14-02-1187]).

The ADSCs used in the present study were obtained from the rat inguinal fat pad, and the cells in the third to fifth passages were positive for the expression of CD29 and CD44, whereas the expression of CD31 (an endothelial cell marker), CD45 (a hematopoietic cell marker) and CD106 (a marker of BMMSCs) were negative.

In addition to measurements of cell surface markers, whether ADSCs have the potential for multidirectional differentiation has also been investigated ([@b20-mmr-14-02-1187]). Under the combined function of Vitamin C, β-sodium glycerophosphate and hexadecadrol, the present study found the presence of a calcific knob, which stained red following Alizarin Red staining. This showed that calcification appeared during the induction of osteogenesis, with extracellular calcium ion deposition and the formation of calcium salt. No similar knobs were found in the contrasting group. Under the combined function of insulin, hexadecadrol, IBMX and indometacin, it was found that small adipose drops gathered, which appeared red on Oil-Red O staining. This was not observed in the contrasting group. All the above experiments demonstrated that the ADSCs exhibited osteogenic and adipogenic differentiation potential.

In the present study, ADSCs were induced and differentiated into Schwann-like cells with various cytokines. β-ME promotes neural differentiation in stem cells by preventing damage to cells of the peroxidase ([@b21-mmr-14-02-1187]). The mechanism involves β-ME increasing the rate of synthesis of glutathione and reducing the cell response to oxygen tension ([@b22-mmr-14-02-1187]). ATRT has an effect on the differentiation of neural stem cells through cell surface receptors, retinoic acid receptors and retinoid X receptors, and these can regulate the expression of certain coding factors, which are critical to the development of neural cell differentiation ([@b23-mmr-14-02-1187]). HRG is a subtype of neuregulin, regarded as an important axonal signal, which can not only prevent apoptosis of SC precursors, but also induce neural crest differentiation into SCs selectively ([@b24-mmr-14-02-1187]). Another study showed that HRG predominately acts on myelination ([@b25-mmr-14-02-1187]). FSK can elevate the level of intracellular cAMP, and cAMP elevation can mimic SC responses in the presence of axons during myelination *in vivo* ([@b26-mmr-14-02-1187]). bFGF has been reported to be involved in cell growth and differentiation. Zhu *et al* ([@b25-mmr-14-02-1187]) demonstrated that bFGF is a major regulator for MSC differentiation into the SC phenotype.

In the present study, immunofluorescence revealed that bipolar, tripolar and even multipolar cells were positive for GFAP, S-100 and P75. To confirm that the results obtained using immunofluorescence were not due to any artefact of cell shrinkage, western blot and RT-qPCR analyses were performed. The Schwann-like cells showed GFAP, S-100 and P75 immunoreactive bands, corresponding to molecular weights of 48,10 and 42 kDa respectively. The results of the RT-qPCR, probed with GFAP, S-100 and P75 primers, also supported the results of the immunofluorescence and western blot analyses. In addition, a previous study showed that this differentiation was lasting and irreversible ([@b27-mmr-14-02-1187]).

In addition, the morphological and phenotypic characteristics did not posses the functions of SCs derived from adipose cells, thus, the present study observed the mitosis of the Schwann-like cells, which increased the numbers of cells in cascades. The results showed that the Schwann-like cells were fully confluent in a short duration once attached, which is beneficial for clinical regeneration following PNI. As for the specific mechanism underlying Schwann-like cell mitotic proliferation, it may be associated with cross-talk between the two cell types by soluble secreted proteins ([@b28-mmr-14-02-1187]), which requires further investigation. The present study hypothesized that this may be associated with activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway and/or inhibition of the caspase pathway, which requires investigation in subsequent experiments. Due to the limitations on research funds and time in the present study, only the mitosis of Schwann-like cells derived from ADSCs were observed. Whether SCs cultured directly from the sciatic nerve or brachial nerve, or from BMMSCs can perform mitosis remains to be elucidated and warrants further investigation to determine their potential benefit. The present study provides broad information that may aid the future development of cell therapy in PNI.
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![Isolation and identification of ADSCs. (A) Primary culture of ADSCs within 24 h; (B) ADSCs in the fourth passage; (C) ADSCs following 10 passages. Scale bar=100 *µ*m. ADSCs were stained using (D) Alizarin Red and (E) Oil-Red O (magnification, ×400). Scale bar=100 *µ*m. (F--H) Flow cytometric analysis of ADSCs. ADSCs, adipose-derived stem cells. FITC, fluorescein isothiocyanate; PE, phycoerythrin; APC, allophycocyanin.](MMR-14-02-1187-g00){#f1-mmr-14-02-1187}

![ADSC differentiation into cells with an SC phenotype. (A) Cultured cells at the early stage of differentiation. (B) ADSCs differentiated into SC phenotype. Immunofluorescence staining of (C) GFAP, (D) S100 and (E) P75. Scale bar=100 *µ*m. Cell nuclei were labeled with DAPI (blue). Detection of (F) GFAP, (G) S100 and (H) P75 proteins using western blot analysis. (I) Relative protein expression levels of GFAP, S100 and P75 (^\*^P\<0.05, vs. ADSCs). 1, ADSCs, 2, Schwann-like cells. (J) Detection of mRNA expression levels of GFAP, S100 and P75 using reverse transcription-quantitative polymerase chain reaction analysis (^\*\*^P\<0.01, vs. ADSCs). Values are presented as the mean ± standard deviation. SC, Schwann cell; ADSCs, adipose-derived stem cells; GFAP, glial fibrillary acidic protein.](MMR-14-02-1187-g01){#f2-mmr-14-02-1187}

![Analysis of the proliferation of Schwann-like cells. (A) a 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay was used to examine the growth rate of Schwann-like cell populations following differentiation for 1, 3, 5, 7, 9 and 11 days. Values are presented as the mean ± standard deviation of triplicate experiments. Images of mitosis of the Schwann-like cells in (B) prophase, (C) metaphase, (D) anaphase and (E) telophase. Scale bar=100 *µ*m.](MMR-14-02-1187-g02){#f3-mmr-14-02-1187}

###### 

Protein expression levels of GFAP, S100 and P75.

  Group                        GFAP                                                        S100                                                        P75
  ---------------------------- ----------------------------------------------------------- ----------------------------------------------------------- -----------------------------------------------------------
  Adipose-derived stem cells   0.417±0.076                                                 0.502±0.150                                                 0.431±0.155
  Schwann-like cells           0.613±0.063[a](#tfn2-mmr-14-02-1187){ref-type="table-fn"}   0.766±0.134[a](#tfn2-mmr-14-02-1187){ref-type="table-fn"}   0.721±0.171[a](#tfn2-mmr-14-02-1187){ref-type="table-fn"}

Values are presented as the mean ± standard deviation.

P\<0.05, vs. adipose-derived stem cells; GFAP, glial fibrillary acidic protein.
